Ouvrages publiés à titre de seul auteur (1)
  1. 1. Dewachter, L. (2010). Pathobiologie de l’hypertension artérielle pulmonaire – Implication des voies de l’angiopoïétine et des protéines de morphogenèse osseuse dans le remodelage vasculaire. Editions universitaires européennes.
    2.   Parties d'ouvrages collectifs (3)
  2. 1. Dewachter, L. (2013). Prolonged overcirculation-induced pulmonary arterial hypertension, as a cause of right ventricular failure. In Treatment Strategies: Respiratory (pp. 63-65). eBook.
  3. 2. Dewachter, L., & Naeije, R. (2009). Animal models of pulmonary hypertension. In Advances in Pulmonary Hypertension (pp. 59-82). CRC Press.
  4. 3. Dewachter, L., & Naeije, R. (2009). Pulmonary Hypertension: Animal models of pulmonary arterial hypertension. In Pulmonary Hypertension, Vol. 236. Lung Biology in Health and Disease (pp. 59-82). M Humbert & JP Lynch.(Marcel Dekker).
    5.   Articles dans des revues avec comité de lecture (52)
  5. 1. Alimoradi, H., Fallah, A., Jespers, P., Bolaky, N., Grégoire, F., Townley, H., Törnroth-Horsefield, S., Shavandi, A., Dewachter, L., & Delporte, C. (2026). Glutathione Responsive iNOS Inhibiting Polymeric Prodrug for Targeted Inhibition of Angiogenesis. Journal of nanobiotechnology, 24, 194.
  6. 2. Garcia, B., ter Schiphorst, B., SANTOS, K., Su, F., Dewachter, L., Vasques-Nóvoa, F., Rocha-Oliveira, E., Roncon-Albuquerque, R., Uba, T., HARTMANN, O., Picod, A., AZIBANI, F., Callebert, J., Goldman, S., Annoni, F., Favory, R., Vincent, J. L., Creteur, J., Taccone, F. S., MEBAZAA, A., & Herpain, A. (2024). Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury. Intensive care medicine experimental, 12(1). doi:10.1186/s40635-024-00638-3
  7. 3. Idouz, K., Belhaj, A., Rondelet, B., Dewachter, L., Flamion, B., Kirschvink, N., & Dogne, S. (2024). Cascading renal injury after brain death: Unveiling glycocalyx alteration and the potential protective role of tacrolimus. Frontiers in Cell and Developmental Biology, 12. doi:10.3389/fcell.2024.1449209
  8. 4. Hubesch, G., Dewachter, C., Chomette, L., Hupkens, E., Jespers, P., Vegh, G., Doppler, M., Sheikh Mohammad, U., Thiriard, A., Remmelink, M., Vachiery, J.-L., McEntee, K., & Dewachter, L. (2024). Early Alteration of Right Ventricle-Pulmonary Artery Coupling in Experimental Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association, 13(11), e032201. doi:10.1161/JAHA.123.032201
  9. 5. Garcia, B., Su, F., Dewachter, L., Wang, Y., Li, N., Remmelink, M., Van Eycken, M., Khaldi, A., Favory, R., Herpain, A., Moreau, A., Moiroux-Sahraoui, A., Manicone, F., Annoni, F., Shi, L., Vincent, J. L., Creteur, J., & Taccone, F. S. (2023). Neutralization of extracellular histones by sodium-Β-O-methyl cellobioside sulfate in septic shock. Critical care, 27(1). doi:10.1186/s13054-023-04741-x
  10. 6. Belhaj, A., Dewachter, L., Monier, A., Vegh, G., Rorive, S., Remmelink, M., Closset, M., Melot, C., Creteur, J., Salmon, I., & Rondelet, B. (2023). Beneficial Effects of Tacrolimus on Brain-Death-Associated Right Ventricular Dysfunction in Pigs. International Journal of Molecular Sciences (CD-ROM), 24(13), 10439. doi:10.3390/ijms241310439
  11. 7. Chomette, L., Hupkens, E., Romitti, M., Dewachter, L., Vachiery, J.-L., Bailly, S., Costagliola, S., Smits, G., Tillet, E., & Bondue, A. (2023). Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity. American journal of medical genetics. Part A. doi:10.1002/ajmg.a.63236
  12. 8. Garcia, B., Su, F., Manicone, F., Dewachter, L., Favory, R., Khaldi, A., Moiroux-Sahroui, A., Moreau, A., Herpain, A., Vincent, J. L., Creteur, J., Taccone, F. S., & Annoni, F. (2023). Angiotensin 1-7 in an experimental septic shock model. Critical care, 27(1), 106. doi:10.1186/s13054-023-04396-8
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Suivant >>